UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Patterns of National Cancer Institute‐Sponsored Clinical Trial Enrollment in Black Adolescents and Young Adults

Cancer medicine (Malden, MA), 2021-11, Vol.10 (21), p.7620-7628

2021

Volltextzugriff (PDF)

Improving Health Equity and Reducing Disparities in Pediatric and Adolescent/Young Adult Oncology: In Support of Clinical Practice Guidelines

Journal of the National Comprehensive Cancer Network, 2021-06, Vol.19 (6), p.765-769

2021

Volltextzugriff (PDF)

Strategies to improve diversity, equity, and inclusion in clinical trials

Cancer, 2022-01, Vol.128 (2), p.216-221

2022

Volltextzugriff (PDF)

Adolescent and young adult lymphoma: collaborative efforts toward optimizing care and improving outcomes

Blood advances, 2017-10, Vol.1 (22), p.1945-1958

2017

Volltextzugriff (PDF)

Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma

Cancer, 2016-09, Vol.122 (17), p.2723-2730

2016

Volltextzugriff (PDF)

Adolescent and young adult Hodgkin lymphoma: Raising the bar through collaborative science and multidisciplinary care

Pediatric blood & cancer, 2018-07, Vol.65 (7), p.e27033-n/a

2018

Volltextzugriff (PDF)

Improving Health Equity and Reducing Pediatric Cancer Disparities: The Role of the Medical Home

Pediatric annals, 2022-01, Vol.51 (1), p.e22

2022

Volltextzugriff (PDF)

Limitations of Applying the Hematopoietic Cell Transplantation Comorbidity Index in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation

Transplantation and cellular therapy, 2021-01, Vol.27 (1), p.74.e1-74.e9

2021

Volltextzugriff (PDF)

Race and socioeconomic status in pediatric allogeneic hematopoietic cell transplantation for nonmalignant conditions

Pediatric blood & cancer, 2020-09, Vol.67 (9), p.e28367-n/a

2020

Volltextzugriff (PDF)

How Variable Is Our Delivery of Information? Approaches to Patient Education About Oral Chemotherapy in the Pediatric Oncology Clinic

Journal of pediatric health care, 2017-01, Vol.31 (1), p.e1-e6

2017

Volltextzugriff (PDF)

Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children’s Oncology Group Study

Journal of clinical oncology, 2019-11, Vol.37 (32), p.3009-3017

2019

Volltextzugriff (PDF)

Initial cancer treatment and survival in children, adolescents, and young adults with Hodgkin lymphoma: A population‐based study

Cancer, 2021-12, Vol.127 (24), p.4613-4619

2021

Volltextzugriff (PDF)

Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia

JNCI : Journal of the National Cancer Institute, 2023-10, Vol.115 (10), p.1179-1187

2023

Volltextzugriff (PDF)

New persistent opioid use among adolescents and young adults with sarcoma

Cancer, 2022-07, Vol.128 (14), p.2777-2785

2022

Volltextzugriff (PDF)

Genome-wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemia

British journal of haematology, 2024-08

2024

Volltextzugriff (PDF)

Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma

Pediatric blood & cancer, 2023-09, Vol.70 (S6), p.e30580-n/a

2023

Volltextzugriff (PDF)

Time to diagnosis among young patients with cancer

Pediatric blood & cancer, 2024-09, Vol.71 (9), p.e30997

2024

Volltextzugriff (PDF)

Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohort

Pediatric blood & cancer, 2024-08, Vol.71 (11), p.e31274

2024

Volltextzugriff (PDF)

Feasibility of oncology clinical trial‐embedded evaluation of social determinants of health

Pediatric blood & cancer, 2022-11, Vol.69 (11), p.e29933-n/a

2022

Volltextzugriff (PDF)

Pediatric and Adolescent Hodgkin Lymphoma: Paving the Way for Standards of Care and Shared Decision Making

American Society of Clinical Oncology educational book, 2024-06, Vol.44 (3), p.e432420-e432420

2024

Volltextzugriff (PDF)

Severe Vincristine-related Neurotoxicity in 5 Patients With Pediatric Acute Lymphoblastic Leukemia Requiring Discontinuation of Vincristine: A Description of Long-term Outcome

Journal of pediatric hematology/oncology, 2021-10, Vol.43 (7), p.e997-e999

2021

Volltextzugriff (PDF)

Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trials

The Lancet. Haematology, 2022-01, Vol.9 (1), p.e49-e57

2022

Volltextzugriff (PDF)

An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana‐Farber Cancer Institute ALL Consortium protocol 05‐001

Pediatric blood & cancer, 2018-03, Vol.65 (3), p.n/a

2018

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(90)

Sprache

Englisch
(89)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Patterns of National Cancer Institute‐Sponsored Clinical Trial Enrollment in Black Adolescents and Young Adults

Improving Health Equity and Reducing Disparities in Pediatric and Adolescent/Young Adult Oncology: In Support of Clinical Practice Guidelines

Strategies to improve diversity, equity, and inclusion in clinical trials

Adolescent and young adult lymphoma: collaborative efforts toward optimizing care and improving outcomes

Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma

Adolescent and young adult Hodgkin lymphoma: Raising the bar through collaborative science and multidisciplinary care

Improving Health Equity and Reducing Pediatric Cancer Disparities: The Role of the Medical Home

Limitations of Applying the Hematopoietic Cell Transplantation Comorbidity Index in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation

Race and socioeconomic status in pediatric allogeneic hematopoietic cell transplantation for nonmalignant conditions

How Variable Is Our Delivery of Information? Approaches to Patient Education About Oral Chemotherapy in the Pediatric Oncology Clinic

Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children’s Oncology Group Study

Initial cancer treatment and survival in children, adolescents, and young adults with Hodgkin lymphoma: A population‐based study

Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia

New persistent opioid use among adolescents and young adults with sarcoma

Genome-wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemia

Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma

Time to diagnosis among young patients with cancer

Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohort

Identification of prognostic factors in childhood T‐cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05‐001 and 11‐001

Feasibility of oncology clinical trial‐embedded evaluation of social determinants of health

Pediatric and Adolescent Hodgkin Lymphoma: Paving the Way for Standards of Care and Shared Decision Making

Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001

Severe Vincristine-related Neurotoxicity in 5 Patients With Pediatric Acute Lymphoblastic Leukemia Requiring Discontinuation of Vincristine: A Description of Long-term Outcome

Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trials

An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana‐Farber Cancer Institute ALL Consortium protocol 05‐001

Suchergebnisse filtern